70-year-old Israel “Izzy” Englander, worth $6 billion to date, was born the same year as the state of Israel, and just one year …
Analysts and investors have all expressed their thoughts on how things will pan out for Bausch Health (BHC) when taking on Synergy’s (SGYP) …
Stifel analyst Annabel Samimy says when it comes to Bausch Health (BHC) stock, patience pays. Recall the company entered a “stalking horse” agreement …
Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.
Bausch Health Companies (BHC) announced today it will acquire some assets of Synergy Pharmaceuticals, which is being called the “stalking horse” agreement – …
J.P Morgan’s Chris Schott recently met with Bausch Health (BHC) management to talk about the future of the pharmaceutical company.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced this morning that its subsidiary Bausch + Lomb has received CE Mark from the European Commission for the …
Is Billionaire fund guru Jim Simons switching OPK for VRX?
Ken Griffin is a man known to be raring to take a risk when it is worthwhile, a daring and strategic mindset that …
Bausch + Lomb, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses in 20 …
